ROCK1 and prostate neoplasm: Lin et al (62) transfected PC3 cells with mir-146a, a microRNA found to be downregulated in hormone-refractory prostate tumors, which targets ROCK1. Suppression of ROCK1 in these prostate cancer cells reduced cell proliferation, invasion capacity and their adhesion potential to bone marrow endothelial cells in vitro.